Published by Josh White on 21st March 2022
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory review and approval of the iron therapy 'Accrufer'.
URL: http://www.digitallook.com/dl/news/story/32545409/...